Pamela Stephenson Zynerba Pharmaceuticals, Inc. (ZYNE) insider trading activity

Pamela Stephenson is of Zynerba Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of ZYNE, which is worth approximately $0. The most recent transaction as insider was on Oct 10, 2023, when has been sold 75,778 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Pamela Stephenson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 10 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	75,778 Reduced 100.0%	0 Common Stock
Jun 14 2023	SELL Open market or private sale	$40 $0.35 p/Share	115 Reduced 0.15%	75,778 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	47,824 Added 38.66%	75,893 Common Stock
Jun 14 2022	SELL Open market or private sale	$40 $1.01 p/Share	40 Reduced 0.14%	28,069 Common Stock
Jun 14 2022	BUY Grant, award, or other acquisition	-	23,109 Added 45.12%	28,109 Common Stock
Aug 03 2021	BUY Grant, award, or other acquisition	-	5,000 Added 50.0%	5,000 Common Stock

Also insider at

ALBO

ALBIREO PHARMA, INC. Healthcare

Chief Commercial Officer

GMTX

Gemini Therapeutics, Inc. Healthcare

Chief Commercial Officer